|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
DE10399032I1
(de)
|
1987-08-28 |
2004-01-29 |
Health Research Inc |
Rekombinante Viren.
|
|
US6673776B1
(en)
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
FR2658432B1
(fr)
|
1990-02-22 |
1994-07-01 |
Medgenix Group Sa |
Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
|
|
AU8200191A
(en)
|
1990-07-09 |
1992-02-04 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
ATE237694T1
(de)
|
1991-08-20 |
2003-05-15 |
Us Gov Health & Human Serv |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5763270A
(en)
|
1995-06-07 |
1998-06-09 |
Genemedicine, Inc. |
Plasmid for delivery of nucleic acids to cells and methods of use
|
|
DE69633565T3
(de)
|
1995-06-15 |
2013-01-17 |
Crucell Holland B.V. |
Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
|
|
US5622856A
(en)
|
1995-08-03 |
1997-04-22 |
Avigen |
High efficiency helper system for AAV vector production
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US7034009B2
(en)
*
|
1995-10-26 |
2006-04-25 |
Sirna Therapeutics, Inc. |
Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
US6048551A
(en)
|
1997-03-27 |
2000-04-11 |
Hilfinger; John M. |
Microsphere encapsulation of gene transfer vectors
|
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6995006B2
(en)
|
1997-09-05 |
2006-02-07 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6943153B1
(en)
|
1999-03-15 |
2005-09-13 |
The Regents Of The University Of California |
Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
|
|
EP1194451A1
(en)
|
1999-07-02 |
2002-04-10 |
Genentech, Inc. |
Fusion peptides comprising a peptide ligand domain and a multimerization domain
|
|
US6596535B1
(en)
|
1999-08-09 |
2003-07-22 |
Targeted Genetics Corporation |
Metabolically activated recombinant viral vectors and methods for the preparation and use
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
US7465583B2
(en)
|
2000-06-01 |
2008-12-16 |
The University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
EP1490113A4
(en)
|
2002-03-20 |
2007-05-02 |
Univ Florida |
RAAV VECTOR COMPOSITIONS AND METHOD FOR TREATING CHOROIDAL NEOVASCULARIZATION
|
|
WO2004079332A2
(en)
|
2003-03-04 |
2004-09-16 |
National Institute Of Advanced Industrial Science And Technology |
Composition and method for increasing efficiency of introduction of target substance into cell
|
|
JP4559429B2
(ja)
|
2003-05-21 |
2010-10-06 |
ジェンザイム・コーポレーション |
空キャプシドを実質的に含まない組換えａａｖビリオン調製物を生成するための方法
|
|
CN100476110C
(zh)
*
|
2003-08-04 |
2009-04-08 |
邱则有 |
一种现浇砼用空腔模壳构件
|
|
CN1997386B
(zh)
|
2004-07-30 |
2012-05-30 |
瑞泽恩制药公司 |
通过阻断vegf介导的活性来治疗i型糖尿病的方法
|
|
CN101094688B
(zh)
*
|
2004-09-13 |
2013-05-01 |
建新公司 |
多聚构建体
|
|
EP1827602B1
(en)
*
|
2004-11-26 |
2011-03-09 |
Novagali Pharma S.A. |
Modulating retinal pigmented epithelium permeaion by inhibiting vegfr-1
|
|
US7765583B2
(en)
|
2005-02-28 |
2010-07-27 |
France Telecom |
System and method for managing virtual user domains
|
|
US20060234347A1
(en)
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
|
US8216575B2
(en)
|
2006-03-31 |
2012-07-10 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
|
|
US20090105245A1
(en)
*
|
2006-12-21 |
2009-04-23 |
Bingaman David P |
Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor
|
|
EP1995309A1
(en)
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
EP2203476B1
(en)
|
2007-09-25 |
2016-10-26 |
Genzyme Corporation |
Compositions and methods for inhibiting interleukin pathways
|
|
EP2227553A4
(en)
|
2007-11-30 |
2011-01-19 |
Scarab Genomics Llc |
Lac expression system
|
|
CN101951925A
(zh)
*
|
2008-02-20 |
2011-01-19 |
建新公司 |
血管发生抑制
|
|
US20100081707A1
(en)
|
2008-02-21 |
2010-04-01 |
Ali Robin R |
Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
|
|
WO2010019263A2
(en)
|
2008-08-15 |
2010-02-18 |
Genzyme Corporation |
Soluble flt constructs for treating cancers
|
|
JP5956331B2
(ja)
|
2009-06-16 |
2016-07-27 |
ジェンザイム・コーポレーション |
組換えａａｖベクターの改良された精製方法
|
|
WO2011126808A2
(en)
|
2010-03-29 |
2011-10-13 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
EP2563395A4
(en)
|
2010-04-30 |
2013-11-27 |
Lpath Inc |
TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES
|
|
TWI698240B
(zh)
*
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
US10640771B2
(en)
|
2013-04-17 |
2020-05-05 |
Genzyme Corporation |
Compositions and methods for treating and preventing macular degeneration
|
|
KR102234695B1
(ko)
|
2014-02-06 |
2021-04-02 |
젠자임 코포레이션 |
황반 변성을 치료하고 예방하기 위한 조성물 및 방법
|